Ok, es sind nur Zellkulturen, aber das klingt doch trotzdem ganz vielversprechend. Vor allem in Verbindung mit den guten statistischen Daten der Phase-II-Studie. Bin gespannt auf die Ergebnisse der Phase-III-Studie.
“In two experiments presented at ECTRIMS, the modulation of S1P-R by the addition of FTY720 resulted in an increase in the number, growth and survival of oligodendrocytes in cell culture. This effect of FTY720 on oligodendrocytes may help limit destruction of myelin and promote its repair and, thus, may contribute to the effectiveness of FTY720 in MS. Oligodendrocytes are cells in the CNS that make a fatty tissue, called myelin, which is necessary for normal signal transfer along nerve fibers in the CNS. Myelin and oligodendrocytes are typically damaged in MS.”